Abridge, Highmark Health testing use of AI for prior authorizations| STAT
Abridge is partnering with payer-provider Highmark Health to develop an artificial intelligence tool that would facilitate in-visit insurance…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
RFK Jr.’s new CDC vaccine panel sparks debate on conflicts
WASHINGTON — When health secretary Robert F. Kennedy Jr. dismissed the 17 members of the key panel that advises…
The little-known architect of $67B in HHS cuts
The relentless drumbeat of cuts to U.S. government research and disease prevention have devastated tens of thousands of…
Trump drug price executive order includes MFN pricing
WASHINGTON — The Trump administration on Monday unveiled a sweeping plan to try to lower prescription drug prices,…
Health care firms seek delay on Trump’s Affordable Care Act rule
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Canada, with court order, advances an antitrust probe into Express Scripts
Canadian officials have obtained a court order that requires Express Scripts to produce documents in connection with an…
On NIH director’s first day, the agency tackles one of his priorities — ending ‘censorship’ in science – STAT
On NIH director’s first day, the agency tackles one of his priorities — ending ‘censorship’ in science STATSenate confirms…
Să schimbăm modul în care facem afaceri şi politică!
Companiile din comunitatea AHK România fac apel la cooperare şi unitate între mediul social, economic şi cel politic…
Why Maia Hightower’s Equality AI startup is shutting down
A day after President Donald Trump rescinded Biden’s executive order urging federal agencies to formulate standards for responsible…
FDA’s draft guidance on use of AI in drug development centers risk
After nearly a decade of machine learning innovation in the drug industry, the U.S. Food and Drug Administration…